EP Patent

EP4242743A3 — Open-field handheld fluorescence imaging systems and methods

Assigned to Stryker Corp · Expires 2023-10-18 · 3y expired

What this patent protects

An imaging device having an imaging field of view, the imaging device including at least one illumination port configured to output light for illuminating a target; an imaging sensor to detect light traveling along an optical path to the imaging sensor; and a first movable window…

USPTO Abstract

An imaging device having an imaging field of view, the imaging device including at least one illumination port configured to output light for illuminating a target; an imaging sensor to detect light traveling along an optical path to the imaging sensor; and a first movable window positioned upstream of the sensor with respect to a direction of travel of light along the optical path, wherein the first movable window is configured to move into the optical path in a deployed position for modifying light received from the target.

Drugs covered by this patent

Patent Metadata

Patent number
EP4242743A3
Jurisdiction
EP
Classification
—
Expires
2023-10-18
Drug substance claim
No
Drug product claim
No
Assignee
Stryker Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.